🔎 Trials Near Me

Početna › Rak prostate › Kansas

Kliničke studije za Rak prostate u državi Kansas

22 studija za Rak prostate traži sudionike na lokacijama u državi Kansas.

Gradovi u državi Kansas

Službeni tekst studije (engleski)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • HaysMed, Hays
  • Lawrence Memorial Hospital, Lawrence
  • The University of Kansas Cancer Center - Olathe, Olathe
  • i još 4
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 2. lis 2026. · NCT06931340

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Central Care Cancer Center - Garden City, Garden City
  • Central Care Cancer Center - Great Bend, Great Bend
  • Veteran Administration Eastern Kansas Healthcare, Leavenworth
  • i još 4
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • University of Kansas Cancer Center, Kansas City
  • The University of Kansas Cancer Center - Olathe, Olathe
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • i još 2
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06632977

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • HaysMed, Hays
  • Lawrence Memorial Hospital, Lawrence
  • The University of Kansas Cancer Center - Olathe, Olathe
  • i još 4
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT03866382

DESTINY-PANTUMOUR04

  • Research Site, Topeka
U tijeku regrutacijaOpažajna studija
Od 18 do 130 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07124000

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • University of Kansas Hospital, Kansas City
U tijeku regrutacijaFaza 2/3
Od 18 do 100 godina · Muškarci · Ažurirano 22. ruj 2026. · NCT06780670

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • University of Kansas Medical Center, Westwood
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 22. ruj 2026. · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • University of Kansas Hospital, Kansas City
U tijeku regrutacijaFaza 3
Od 18 do 100 godina · Muškarci · Ažurirano 22. ruj 2026. · NCT06855277

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

  • University of Kansas Medical Center, Kansas City
U tijeku regrutacijaFaza 1
Od 18 godina i više · Muškarci · Ažurirano 15. ruj 2026. · NCT07581184

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • Wichita Urology Group, Wichita
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 11. ruj 2026. · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • University of Kansas Cancer Center, Kansas City
  • Lawrence Memorial Hospital, Lawrence
  • The University of Kansas Cancer Center - Olathe, Olathe
  • i još 3
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 10. ruj 2026. · NCT05946213

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • Kansas University Cancer Center, Kansas City
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 24. kol 2026. · NCT07745361

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  • MidAmerica Cancer Care, Merriam
U tijeku regrutacijaFaza 1
Od 18 godina i više · Muškarci · Ažurirano 21. kol 2026. · NCT04221542

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Central Care Cancer Center - Garden City, Garden City
  • Mercy Hospital Pittsburg, Pittsburg
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 19. kol 2026. · NCT04423211

HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer

  • University of Kansas Health System, Kansas City
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT03802851

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Instititute - South, Overland Park
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699

TERPS Trial for de Novo Oligometastic Prostate Cancer

  • KU Medical Center- Cancer Center, Kansas City
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 3. lip 2026. · NCT05223803

Study of AZD0754 in Participants With Metastatic Prostate Cancer

  • Research Site, Westwood
U tijeku regrutacijaFaza 1/2
Od 18 do 130 godina · Muškarci · Ažurirano 23. velj 2026. · NCT06267729

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

  • Wichita Urology Group, Wichita
U tijeku regrutacijaFaza 1
Od 18 godina i više · Muškarci · Ažurirano 4. velj 2026. · NCT04729114

Vitamin D for Prostate Endocrine Therapy

  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Health System Saint Francis Campus, Topeka
  • i još 1
U tijeku regrutacijaFaza 3
Od 50 godina i više · Muškarci · Ažurirano 15. sij 2026. · NCT05838716

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • University of Kansas Cancer Center, Kansas City
  • Olathe Health Cancer Center, Olathe
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 11. ruj 2025. · NCT03678025

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.